CVE:CRM

CRH Medical Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.67 million shs
Average Volume5.83 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive CRM News and Ratings via Email

Sign-up to receive the latest news and ratings for CRH Medical and its competitors with MarketBeat's FREE daily newsletter.


CRH Medical logo

About CRH Medical

CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV. In addition to the product, CRH delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its Web-based platform to connect doctors with patients, as well as educating its install base of physicians.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











CRH Medical (CVE:CRM) Frequently Asked Questions

What stocks does MarketBeat like better than CRH Medical?

Wall Street analysts have given CRH Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CRH Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are CRH Medical's key executives?

CRH Medical's management team includes the following people:
  • Anthony F. Holler M.D., Independent Chairman of the Board (Age 63)
  • Edward J. Wright, Chief Executive Officer, Director
  • Richard K. Bear, Chief Financial Officer (Age 48)
  • Jay Kreger, President of CRH Anesthesia Management
  • David Johnson, Independent Director
  • Bergein F. Overholt M.D., Independent Director
  • Todd R. Patrick, Independent Director (Age 48)
  • Ian A. Webb, Independent Director (Age 61)

Who are some of CRH Medical's key competitors?

What other stocks do shareholders of CRH Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CRH Medical investors own include Intel (INTC), Micron Technology (MU), PayPal (PYPL), Cisco Systems (CSCO), Dollar General (DG), Johnson & Johnson (JNJ), AbbVie (ABBV), Adobe (ADBE), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

What is CRH Medical's stock symbol?

CRH Medical trades on the Canadian Venture Exchange (CVE) under the ticker symbol "CRM."

How do I buy shares of CRH Medical?

Shares of CRM and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How many employees does CRH Medical have?

CRH Medical employs 56,606 workers across the globe.

What is CRH Medical's official website?

The official website for CRH Medical is investors.crhsystem.com.

Where are CRH Medical's headquarters?

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.


This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.